AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Volatile Non-Invasive Biomarkers of Epileptic Seizures

Recruitingn/aAges 18 Years - anyAllUniversity College London Hospitals
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Breath and sweat samples will be collected from people who have been admitted to hospital after a potential seizure and analysed by the team. The researchers then hope to identify a pattern of small molecules that can distinguish seizures from other events, and perhaps determine the severity of the seizure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patients who have been admitted to either University College London's Queen's Square EEG-telemetry unit or Chalfont Centre for Epilepsy, for diagnosis of seizure events. 2. Patients aged 18 years or above Exclusion Criteria: 1. Patients with active infection or who have taken antibiotics within 4 weeks 2. Patients on immunosuppressive medications 3. Patients with co-morbidities preventing breath collection 4. Patients unable to provide informed consent.
๐Ÿ’Š

What it tests

  • Sample Collection
๐Ÿ“

Where

2 sites
Chalfont Centre for Epilepsy
London, United Kingdom
National Hospital for Neurology and Neurosurgery
London, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy